Physician profile
Steven Brown
NPI 1386629160
$213.77
in general payments reported to CMS, 2019-2025
7 companies · $54.07 in 2025
The $54.07 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.80 · 2020: $15.26 · 2022: $53.05 · 2023: $56.89 · 2024: $15.70 · 2025: $54.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.66 · Consulting Fee: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.66 |
| Consulting Fee | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $80.00 | 2022-2023 | Surgipro Ll |
| Avita Medical Americas, LLC | $32.20 | 2025 | Cohealyx, Permeaderm, Recell |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.31 | 2020-2022 | |
| Solventum Corporation | $21.87 | 2025 | Prevena |
| Shire North American Group INC | $18.80 | 2019 | |
| Smith+Nephew, INC. | $16.89 | 2023 | Collagenase Santyl, Regranex |
| Takeda Pharmaceuticals U.S.A., INC. | $15.70 | 2024 | Entyvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.